Clicky

Intelligent Bio Solutions Inc.(INBS) News

Date Title
Jun 25 Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
Jun 18 Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
Jun 18 EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout
Jun 17 IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc.
May 27 IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
May 22 IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
May 22 Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
May 15 IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
May 15 Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
May 13 IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
May 13 Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
May 13 EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%
Mar 11 Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
Feb 21 Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
Feb 20 Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
Feb 19 Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
Feb 15 Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024)
Feb 13 Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
Feb 11 Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy
Feb 10 Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy